A20/TNFAIP3 heterozygosity predisposes to behavioral symptoms in a mouse model for neuropsychiatric lupus

Brain, Behavior, & Immunity - Health - Tập 2 - Trang 100018 - 2020
C. Daems1, M. Sékulic1, V. Vulsteke1, G. van Loo2,3, R. D’Hooge4, Z. Callaerts-Végh4, P. Callaerts1
1Laboratory of Behavioral and Developmental Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium
2VIB-UGent Center for Inflammation Research, Gent, Belgium
3Department of Biomedical Molecular Biology, Ghent University, Gent, Belgium
4Laboratory of Biological Psychology, KU Leuven, Leuven, Belgium

Tài liệu tham khảo

ACR, 1999, The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes, Arthritis Rheum., 42, 599, 10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F Adrianto, 2011, Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus, Nat. Genet., 43, 253, 10.1038/ng.766 Appenzeller, 2008, Acute psychosis in systemic lupus erythematosus, Rheumatol. Int., 28, 237, 10.1007/s00296-007-0410-x Barrientos, 2015, Neuroinflammation in the normal aging hippocampus, Neuroscience, 309, 84, 10.1016/j.neuroscience.2015.03.007 Bendorius, 2018, From systemic inflammation to neuroinflammation: the case of neurolupus, Int. J. Mol. Sci., 19, 3588, 10.3390/ijms19113588 Bennett, 2016, New tools for studying microglia in the mouse and human CNS, Proc. Natl. Acad. Sci., 113, E1738, 10.1073/pnas.1525528113 Berchtold, 2008, Gene expression changes in the course of normal brain aging are sexually dimorphic, Proc. Natl. Acad. Sci., 105, 15605, 10.1073/pnas.0806883105 Bernier, 2009, Combined oral contraceptive use and the risk of systemic lupus erythematosus, Arthritis Rheum., 61, 476, 10.1002/art.24398 Blumenreich, 1990, The white blood cell and differential count, 724 Bortoluzzi, 2018, Attribution of neuropsychiatric manifestations to systemic lupus erythematosus, Front. Med., 5, 1, 10.3389/fmed.2018.00068 Bosanac, 2010, Ubiquitin binding to A20 ZnF4 is required for modulation of NF-kB signaling, Mol. Cell, 40, 548, 10.1016/j.molcel.2010.10.009 Brody, 2006, Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injury, Exp. Neurol., 197, 330, 10.1016/j.expneurol.2005.10.020 Bryant, 2010, The molecular basis of the host response to lipopolysaccharide, Nat. Rev. Microbiol., 8, 8, 10.1038/nrmicro2266 Buyon, 2005, The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in, Systemic Lupus. Ann. Intern. Med., 142, 953, 10.7326/0003-4819-142-12_Part_1-200506210-00004 Callaerts-Végh, 2006, Concomitant deficits in working memory and fear extinction are functionally dissociated from reduced anxiety in metabotropic glutamate receptor 7-deficient mice, J. Neurosci., 26, 6573, 10.1523/JNEUROSCI.1497-06.2006 Callaerts-Végh, 2012, LPA 5 receptor plays a role in pain sensitivity , emotional, Genes Brain Behav., 11, 1009 Costenbader, 2007, Reproductive and menopausal factors and risk of systemic lupus erythematosus in women, Arthritis Rheum., 56, 1251, 10.1002/art.22510 Crampton, 2014, Linking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosus, Dis. Model. Mech., 7, 1033, 10.1242/dmm.016451 D’Hooge, 2001, Applications of the Morris water maze in the study of learning and memory, Brain Res. Rev., 36, 60, 10.1016/S0165-0173(01)00067-4 D’Hooge, 2005, Neurocognitive and psychotiform behavioral alterations and enhanced hippocampal long-term potentiation in transgenic mice displaying neuropathological features of human alpha-mannosidosis, Neurobiol. Dis., 25, 6539 Damani, 2011, Age-related alterations in the dynamic behavior of microglia, Aging Cell, 10, 263, 10.1111/j.1474-9726.2010.00660.x De, 2014, The deubiquitinase activity of A20 is dispensable for NF-kB signaling, EMBO Rep., 15, 775, 10.15252/embr.201338305 Devraj, 2018, An in vivo blood-brain barrier permeability assay in mice using fluorescently labeled tracers, J. Vis. Exp., 132 Di Benedetto, 2017, Contribution of neuroinflammation and immunity to brain aging and the mitigating effects of physical and cognitive interventions, Neurosci. Biobehav. Rev., 75, 114, 10.1016/j.neubiorev.2017.01.044 Duan, 2019, A de novo frameshift mutation in TNFAIP3 impairs A20 deubiquitination function to cause neuropsychiatric systemic lupus erythematosus, J. Clin. Immunol., 39, 795, 10.1007/s10875-019-00695-4 Evans, 2004, Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity, Biochem. J., 378, 727, 10.1042/bj20031377 Fayyaz, 2015, Haematological manifestations of lupus, Lupus Sci. Med., 2, 10.1136/lupus-2014-000078 Flo, 2004, Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron, Nature, 432, 917, 10.1038/nature03104 Flurkey, 2007, The mouse in aging research, 637 Gelb, 2018, Mechanisms of neuropsychiatric lupus ​: the relative roles of the blood- cerebrospinal fl uid barrier versus blood-brain barrier, J. Autoimmun., 91, 34, 10.1016/j.jaut.2018.03.001 Grag, 2013, The deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling, Sci. Signal., 6, ra44 Graham, 2008, Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus, Nat. Genet., 40, 1059, 10.1038/ng.200 Guedes, 2014, A20 deficiency causes spontaneous neuroinflammation in mice, J. Neuroinflammation, 11, 1, 10.1186/1742-2094-11-122 Hanly, 2014, Diagnosis and management of neuropsychiatric SLE, Nat. Rev. Rheumatol., 10, 338, 10.1038/nrrheum.2014.15 Hanly, 2005, Management of neuropsychiatric lupus, Best Pract. Res. Clin. Rheumatol., 19, 799, 10.1016/j.berh.2005.04.003 Hanly, 2007, Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus an international inception cohort study, Arthritis Rheum., 56, 265, 10.1002/art.22305 Hanly, 2010, Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus, Ann. Rheum. Dis., 69, 529, 10.1136/ard.2008.106351 Hellemans, 2007, qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data, Genome Biol., 8, R19, 10.1186/gb-2007-8-2-r19 Hughes, 2014, Modulation of autoimmune rheumatic diseases by oestrogen and progesterone, Nat. Rev. Rheumatol., 10, 740, 10.1038/nrrheum.2014.144 Jeltsch-David, 2014, Neuropsychiatric systemic lupus erythematosus ​: pathogenesis and biomarkers, Nat. Rev. Neurol., 10, 579, 10.1038/nrneurol.2014.148 Kale, 2018, BCL-2 family proteins: changing partners in the dance towards death, Cell Death Differ., 25, 65, 10.1038/cdd.2017.186 Kaul, 2016, Systemic lupus erythematosus, Nat. Rev. Dis. Primers, 2, 16039, 10.1038/nrdp.2016.39 Klein, 2016, Sex differences in immune responses, Nat. Rev. Immunol., 16, 626, 10.1038/nri.2016.90 Kohl, 2013, Prepulse inhibition in psychiatric disorders - apart from schizophrenia, J. Psychiatr. Res., 47, 445, 10.1016/j.jpsychires.2012.11.018 Lee, 2000, Failure to regulate TNF-induced NF-kB and cell death responses in A20-deficient mice, Science, 289, 2350, 10.1126/science.289.5488.2350 Li, 2017, Microglia and macrophages in brain homeostasis and disease, Nat. Rev. Immunol., 18, 225, 10.1038/nri.2017.125 Lo, 2013, Neurobiology of Disease Tauroursodeoxycholic acid ( TUDCA ) supplementation prevents cognitive impairment and amyloid deposition in APP/PS1 mice, Neurobiol. Dis., 50, 21, 10.1016/j.nbd.2012.09.003 Love, 1990, Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance, Ann. Intern. Med., 112, 682, 10.7326/0003-4819-112-9-682 Lu, 2013, Article dimerization and ubiquitin mediated recruitment of A20 , a complex deubiquitinating enzyme, Immunity, 38, 896, 10.1016/j.immuni.2013.03.008 Ma, 2012, A20: linking a complex regulator of ubiquitylation to immunity and human disease, Nat. Rev. Genet., 12, 774, 10.1038/nri3313 Magro-Checa, 2019, Are serum autoantibodies associated with brain changes in systemic lupus erythematosus? MRI data from the Leiden NP-SLE cohort, Lupus, 28, 94, 10.1177/0961203318816819 Mak, 2009, Clinical implications of neuropsychiatric systemic lupus erythematosus, Adv. Psychiatr. Treat., 15, 451, 10.1192/apt.bp.108.005785 Mangold, 2017, Sexually divergent induction of microglial- associated neuroinflammation with hippocampal aging, J. Neuroinflammation, 14, 1, 10.1186/s12974-017-0920-8 Mena, 2016, Reduced prepulse inhibition as a biomarker of schizophrenia, Front. Behav. Neurosci., 10, 202, 10.3389/fnbeh.2016.00202 Mike, 2019, Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus, J. Autoimmun., 96, 59, 10.1016/j.jaut.2018.08.005 Monastero, 2001, Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations, J. Neurol. Sci., 184, 33, 10.1016/S0022-510X(00)00492-5 Montero-Lopéz, 2016, The effects of corticosteroids on cognitive flexibility and decision-making in women with lupus, Lupus, 25, 1470, 10.1177/0961203316642313 Musone, 2008, Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus, Nat. Genet., 40, 1062, 10.1038/ng.202 Nadler, 2004, Automated apparatus for quantitation of social approach behaviors in mice, Genes Brain Behav., 3, 303, 10.1111/j.1601-183X.2004.00071.x Naert, 2011, Nocturnal hyperactivity , increased social novelty preference and delayed extinction of fear responses in post-weaning socially isolated mice, Brain Res. Bull., 85, 354, 10.1016/j.brainresbull.2011.03.027 Naert, 2011, Vglut2 haploinsufficiency enhances behavioral sensitivity to MK-801 and amphetamine in mice, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 35, 1316, 10.1016/j.pnpbp.2011.03.023 Niraula, 2017, Microglia priming with aging and stress, Neuropsychopharmacol. Rev., 42, 318, 10.1038/npp.2016.185 Paradee, 1999, Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function, Neuroscience, 94, 185, 10.1016/S0306-4522(99)00285-7 Perry, 2014, Microglial priming in neurodegenerative disease, Nat. Rev. Neurol., 10, 217, 10.1038/nrneurol.2014.38 Petri, 2002, Epidemiology of systemic lupus erythematosus, Best Pract. Res. Clin. Rheumatol., 16, 847, 10.1053/berh.2002.0259 Petri, 2010, Depression and cognitive impairment in newly diagnosed systemic lupus erythematosus, J. Rheumatol., 37, 2032, 10.3899/jrheum.091366 Pikman, 2017, Neuropsychiatric SLE: from animal model to human, Lupus, 26, 470, 10.1177/0961203317694261 Pisetsky, 2019 Rees, 2017, The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies, Rheumatology, 56, 1945, 10.1093/rheumatology/kex260 Rensing-ehl, 2014, Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency, Blood, 124, 851, 10.1182/blood-2014-03-564286 Ribeiro, 2017, The role of infections in neuropsychiatric lupus, Lupus, 26, 490, 10.1177/0961203317691375 Rubtsov, 2010, Genetic and hormonal factors in female-biased autoimmunity, Autoimmun. Rev., 9, 494, 10.1016/j.autrev.2010.02.008 Rubtsova, 2015, Sexual dimorphism in autoimmunity, J. Clin. Investig., 125, 2187, 10.1172/JCI78082 Schmittgen, 2008, Analyzing real-time PCR data by the comparative C(T) method, Nat. Protoc., 3, 1101, 10.1038/nprot.2008.73 Schwartz, 2019, Neuropsychiatric lupus: new mechanistic insights and future treatment directions, Nat. Rev. Rheumatol., 15, 137, 10.1038/s41584-018-0156-8 Shen, 2006, Identification of common transcriptional regulatory elements in interleukin-17 target genes, J. Biol. Chem., 281, 24138, 10.1074/jbc.M604597200 Shimojima, 2005, Relationship between clinical factors and neuropsychiatric manifestations in systemic lupus erythematosus, Clin. Rheumatol., 24, 469, 10.1007/s10067-004-1060-y Skaug, 2011, Direct, noncatalytic mechanism of IKK inhibition by A20, Mol. Cell, 44, 559, 10.1016/j.molcel.2011.09.015 Stewart, 1993, The watermaze, Behav. Neurosci., 1, 107 Stock, 2015, Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice, J. Neuroinflammation, 12, 10.1186/s12974-015-0423-4 Stock, 2013, Neuropsychiatric lupus, the blood brain barrier, and the TWEAK/Fn14 pathway, Front. Immunol., 4, 1, 10.3389/fimmu.2013.00484 Streit, 2004, Dystrophic microglia in the aging human brain, Glia, 45, 208, 10.1002/glia.10319 Studer, 2015, Significant lethality following liver resection in A20 heterozygous knockout mice uncovers a key role for A20 in liver regeneration, Cell Death Differ., 22, 2068, 10.1038/cdd.2015.52 Sweeney, 2019, Blood-Brain barrier: from physiology to disease and back, Physiol. Rev., 99, 21, 10.1152/physrev.00050.2017 Swerdlow, 2008, Realistic expectations of prepulse inhibition in translational models for schizophrenia research, Psychopharmacology (Berl), 199, 331, 10.1007/s00213-008-1072-4 van Dam, 1994, Psychiatric symptoms before systemic lupus erythematosus is diagnosed, Rheumatol. Int., 14, 57, 10.1007/BF00300248 Vendrell, 2007, A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells, Oncogene, 26, 4656, 10.1038/sj.onc.1210269 Vereecke, 2010, Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis, J. Exp. Med., 207, 1513, 10.1084/jem.20092474 Verhelst, 2012, A20 inhibits LUBAC-mediated NF-kB activation by binding linear polyubiquitin chains via its zinc finger 7, EMBO J., 31, 3845, 10.1038/emboj.2012.240 Vincent, 2013, Clinical associations of serum interleukin-17 in systemic lupus erythematosus, Arthritis Res. Ther., 15, R97, 10.1186/ar4277 Voet, 2018, A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation, Nat. Commun., 9, 2036, 10.1038/s41467-018-04376-5 Wang, 2016, TALEN-mediated enhancer knockout in fluences TNFAIP3 gene expression and mimics a molecular phenotype associated with systemic lupus erythematosus, Nat. Genet., 17, 165 Wang, 2013, An enhancer element harboring variants associated with systemic lupus erythematosus engages the TNFAIP3 promoter to influence A20 expression, PLoS Genet., 9, 10.1371/journal.pgen.1003750 Wang, 2013, Astrocytic A20 ameliorates experimental autoimmune encephalomyelitis by inhibiting NF-κB- and STAT1-dependent chemokine production in astrocytes, Acta Neuropathol., 126, 711, 10.1007/s00401-013-1183-9 Watson, 1992, Genetic analysis of MRL/lpr mice: relationship of the Fas apoptotis gene to disease manifestations and renal disease-modifying loci, J. Exp. Med., 176, 1645, 10.1084/jem.176.6.1645 Wen, 2016, B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus, J. Neuroinflammation, 13, 1, 10.1186/s12974-016-0537-3 Wertz, 2015, Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation, Nature, 528, 370, 10.1038/nature16165 Wertz, 2004, De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kB signaling, Nature, 430, 694, 10.1038/nature02794 Willems, 2008, Standardization of real-time PCR gene expression data from independent biological replicates, Anal. Biochem., 379, 127, 10.1016/j.ab.2008.04.036 Yi Li, 2000, The IAP family: endogenous caspase inhibitors with multiple biological activities, Cell Res., 10, 169, 10.1038/sj.cr.7290046 Zamanian, 2012, Genomic analysis of reactive astrogliosis, J. Neurosci., 32, 6391, 10.1523/JNEUROSCI.6221-11.2012 Zandman-Goddard, 2012, Environment and lupus-related diseases, Lupus, 21, 241, 10.1177/0961203311426568 Zhang, 2017, 30 Years of NF-κB: a blossoming of relevance to human pathobiology, Cell, 168, 37, 10.1016/j.cell.2016.12.012 Zhang, 2014, An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex, J. Neurosci., 34, 11929, 10.1523/JNEUROSCI.1860-14.2014 Zhou, 2015, Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease, Nat. Genet., 48, 67, 10.1038/ng.3459